Lin BioScience, Inc.

TPEX:6696 Voorraadrapport

Marktkapitalisatie: NT$13.1b

Lin BioScience Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Irene Wang

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO2.2yrs
Eigendom CEO0.7%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

We're Hopeful That Lin BioScience (GTSM:6696) Will Use Its Cash Wisely

Mar 24
We're Hopeful That Lin BioScience (GTSM:6696) Will Use Its Cash Wisely

We're Hopeful That Lin BioScience (GTSM:6696) Will Use Its Cash Wisely

Dec 10
We're Hopeful That Lin BioScience (GTSM:6696) Will Use Its Cash Wisely

CEO

Irene Wang

2.2yrs

Tenure

Dr. Zhengqi Wang, also known as Irene, PhD, MBA, serves as CSO of Lin BioScience, Inc and also serves as its President since September 2022. Dr. Wang joined Lin BioScience as a founding Employee in 2016 as...